Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection
Clinical trial NCT04225780 · UNKNOWN
Trial details
- NCT number
- NCT04225780
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-01
- Primary completion
- 2020-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.